 CHARLOTTESVILLE, VA ACCESSWIRE October 5, 2021 Adial Pharmaceuticals, Inc. NASDAQ:ADIL;ADILW Adial or the Company, a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that the Company has been invited to present at the Fall Harvest - Best Ideas from the Buy-Side conference, which is being held virtually this week, October 5 - 8, 2021. William Stilley, Chief Executive Officer and President of Adial Pharmaceuticals, will present at the conference. 